abrdn Life Sciences Investors (NYSE:HQL) Declares Quarterly Dividend of $0.62

abrdn Life Sciences Investors (NYSE:HQL) announced a quarterly dividend on Tuesday, August 11th. Investors of record on Monday, August 24th will be paid a dividend of 0.62 per share on Monday, August 31st. This represents a c) annualized dividend and a dividend yield of 11.7%. The ex-dividend date of this dividend is Monday, August 24th. This is a 10.7% increase from abrdn Life Sciences Investors’s previous quarterly dividend of $0.56.

abrdn Life Sciences Investors Stock Performance

Shares of NYSE:HQL traded up $0.11 during mid-day trading on Wednesday, hitting $21.21. 35,821 shares of the company traded hands, compared to its average volume of 126,918. The firm’s 50 day simple moving average is $19.11 and its 200 day simple moving average is $17.81. abrdn Life Sciences Investors has a 52-week low of $13.44 and a 52-week high of $21.32.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.